Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00462202
Recruitment Status : Terminated (Interim analysis of efficacy trial showed no drug efficacy.)
First Posted : April 18, 2007
Last Update Posted : March 3, 2017
Collaborative Study Group (CSG)
Information provided by (Responsible Party):
Keryx Biopharmaceuticals

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : March 2008
  Study Completion Date : March 2008
  Certification/Extension First Submitted : April 13, 2015